The Hidden Epidemic: Spotlight on the Unseen Impact of RSV on Adult Health
Below are some key learning points to help reinforce the impact of this activity.
- Globally, RSV infection represents a significant healthcare burden in older adults that is often underestimated. RSV infection accounts for 10.6% of hospitalizations for pneumonia, 11.4% of hospitalizations for COPD and 5.4% of hospitalizations for congestive cardiac failure.
- Compared with influenza, RSV is associated with greater odds of prolonged hospital stay, pneumonia, ICU admission, COPD exacerbation and 1-year mortality.
- Risk factors for severe RSV and complications include advanced age, immunocompromised status, and cardiopulmonary comorbidity.
- Breakthroughs in vaccine research have led to a new era in RSV prevention that will help reduce the burden of RSV in older adults. There are currently 2 vaccines that have been FDA and EMA approved for use in older adults, with an efficacy rate ranging from 66.7% to 94.1%.
No hay comentarios:
Publicar un comentario